Skip to main content

Table 1 Baseline characteristics based on luteolin intake among patients with type 2 diabetes mellitus

From: Luteolin intake is negatively associated with all-cause and cardiac mortality among patients with type 2 diabetes mellitus

Characteristic

Total

Luteolin intake (mg/day)

P value

Tertile 1

Tertile 2

Tertile 3

[0.005,0.195)

[0.195,0.640)

[0.640,9.870]

Number of patients

2461

841

803

817

 

Age, years

61.28 ± 0.42

60.69 ± 0.74

61.80 ± 0.72

61.36 ± 0.62

0.560

Gender (%)

    

0.040*

 Female

1222 (50.63)

432 (52.54)

410 (54.01)

380 (45.95)

 

 Male

1239 (49.37)

409 (47.46)

393 (45.99)

437 (54.05)

 

Race (%)

    

0.001*

 Non-Hispanic White

971 (63.58)

340 (65.30)

312 (61.43)

319 (63.86)

 

 Non-Hispanic Black

603 (14.37)

247 (17.98)

207 (15.23)

149 (10.30)

 

 Others

887 (22.05)

254 (16.72)

284 (23.35)

349 (25.84)

 

Educational attainment (%)

    

< 0.001*

 Below high school

407 (9.34)

147 (9.07)

137 (10.61)

123 (8.49)

 

 High school or equivalent

1002 (40.64)

379 (46.53)

347 (44.87)

276 (31.55)

 

 College or above

1052 (50.02)

315 (44.41)

319 (44.52)

418 (59.96)

 

Body mass index, kg/m2

33.34 ± 0.26

33.64 ± 0.37

32.74 ± 0.35

33.58 ± 0.43

0.150

Family income-poverty ratio (%)

    

0.002*

 ≤1.0

475 (13.35)

201 (16.73)

167 (13.67)

107 (9.96)

 

 1.0–3.0

1178 (41.81)

422 (45.01)

384 (42.88)

372 (37.94)

 

 >3.0

808 (44.84)

218 (38.26)

252 (43.45)

338 (52.10)

 

Leisure-time physical activity (%)

    

< 0.001*

 No or unable

1662 (62.90)

619 (70.43)

562 (66.29)

481 (53.04)

 

 Moderate

621 (28.67)

179 (25.00)

189 (25.38)

253 (34.89)

 

 Vigorous

178 (8.43)

43 (4.57)

52 (8.33)

83 (12.07)

 

Smoking status (%)

    

0.010*

 Never smoker

1210 (49.51)

390 (48.45)

398 (48.77)

422 (51.12)

 

 Former smoker

872 (35.87)

286 (32.47)

282 (36.20)

304 (38.72)

 

 Current smoker

379 (14.62)

165 (19.09)

123 (15.03)

91 (10.16)

 

Alcohol consumption (%)

    

< 0.001*

 Non-drinker

1235 (44.32)

462 (48.53)

427 (47.67)

346 (37.53)

 

 Mild drinker

554 (25.14)

138 (18.87)

176 (22.68)

240 (33.04)

 

 Heavy drinker

672 (30.54)

241 (32.59)

200 (29.65)

231 (29.43)

 

Energy intake (%)

    

0.002*

 <1500 kcal/day

971 (34.37)

389 (40.73)

318 (35.82)

264 (27.27)

 

 ≥1500 kcal/day

1490 (65.63)

452 (59.27)

485 (64.18)

553 (72.73)

 

Hypertension (%)

    

0.001*

 No

632 (27.66)

193 (20.67)

209 (33.36)

230 (29.15)

 

 Yes

1829 (72.34)

648 (79.33)

594 (66.64)

587 (70.85)

 

Hyperlipidemia (%)

    

0.130

No

314 (11.05)

109 (12.33)

112 (12.43)

93 (8.66)

 

Yes

2147 (88.95)

732 (87.67)

691 (87.57)

724 (91.34)

 

HbA1c, %

7.02 ± 0.04

7.02 ± 0.06

6.99 ± 0.07

7.04 ± 0.07

0.880

Fasting blood glucose, mmol/L

8.34 ± 0.09

8.29 ± 0.20

8.21 ± 0.14

8.50 ± 0.14

0.340

Duration of diabetes, years

10.19 ± 0.29

9.78 ± 0.40

10.49 ± 0.50

10.33 ± 0.43

0.480

Use of oral anti-diabetic agents (%)

    

0.500

 No

1084 (46.84)

377 (47.37)

347 (44.27)

360 (48.59)

 

 Yes

1377 (53.16)

464 (52.63)

456 (55.73)

457 (51.41)

 

Use of insulin (%)

    

0.070

 No

2054 (82.79)

684 (80.65)

662 (81.08)

708 (86.26)

 

 Yes

407 (17.21)

157 (19.35)

141 (18.92)

109 (13.74)

 
  1. The continuous variable is presented as weighted mean ± standard error. The categorical variable is presented as unweighted count (weighted percentage)
  2. *P < 0.05